376 related articles for article (PubMed ID: 16377509)
1. Transarterial chemoembolization for hepatocellular carcinoma.
Lau WY; Yu SC; Lai EC; Leung TW
J Am Coll Surg; 2006 Jan; 202(1):155-68. PubMed ID: 16377509
[No Abstract] [Full Text] [Related]
2. Transarterial chemoembolization, transarterial chemotherapy, and intra-arterial chemotherapy for hepatocellular carcinoma treatment.
Tsochatzis EA; Germani G; Burroughs AK
Semin Oncol; 2010 Apr; 37(2):89-93. PubMed ID: 20494700
[TBL] [Abstract][Full Text] [Related]
3. [Acute renal failure as a complication of transarterial chemoembolization in a patient with hepatocellular carcinoma].
La Spada E; La Spada M; Brusca T; Campagna ME; Di Gesaro V; Terranova A; Sandonato L; Soresi M
Recenti Prog Med; 2007 Apr; 98(4):232-5. PubMed ID: 17547360
[TBL] [Abstract][Full Text] [Related]
4. Massive gastric ulceration after transarterial chemoembolization for hepatocellular carcinoma.
Morante A; Romano M; Cuomo A; de Sio I; Cozzolino A; Mucherino C; Salerno R; Blanco Cdel V; Romano M
Gastrointest Endosc; 2006 Apr; 63(4):718-20. PubMed ID: 16564887
[No Abstract] [Full Text] [Related]
5. TACE it or leave it: hard choices for intermediate-stage hepatocellular carcinoma patients beyond perfect health.
Peck-Radosavljevic M
Liver Int; 2010 Jan; 30(1):3-4. PubMed ID: 19929902
[No Abstract] [Full Text] [Related]
6. Transarterial chemoembolization for hepatocellular carcinoma with portal vein invasion: a helpful palliative approach.
Schumacher G; Gebauer B
J Gastroenterol Hepatol; 2009 Aug; 24(8):1317-9. PubMed ID: 19702898
[No Abstract] [Full Text] [Related]
7. Which transarterial therapy is best for hepatocellular carcinoma?--the evidence to date.
Tsochatzis E; Meyer T; Marelli L; Burroughs AK
J Hepatol; 2010 Sep; 53(3):588. PubMed ID: 20472319
[No Abstract] [Full Text] [Related]
8. Chemoembolization for small hepatocellular carcinoma.
Nakamura H; Oi H
Gan To Kagaku Ryoho; 1997 May; 24 Suppl 1():144-7. PubMed ID: 9210897
[No Abstract] [Full Text] [Related]
9. Transarterial chemoembolization in Child-Pugh class B patients with hepatocellular carcinoma: between the devil and the deep blue sea.
Giannini EG; Savarino V; Risso D; Di Nolfo MA; Del Poggio P; Benvegnù L; Farinati F; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F;
Liver Int; 2010 Jul; 30(6):923-4; author reply 924-5. PubMed ID: 20214738
[No Abstract] [Full Text] [Related]
10. Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy.
Brown DB; Cardella JF; Sacks D; Goldberg SN; Gervais DA; Rajan D; Vedantham S; Miller DL; Brountzos EN; Grassi CJ; Towbin RB
J Vasc Interv Radiol; 2006 Feb; 17(2 Pt 1):225-32. PubMed ID: 16517768
[No Abstract] [Full Text] [Related]
11. [Local, non-surgical treatment of hepatocellular carcinoma].
Roche A
Ann Chir; 1998; 52(1):75-8. PubMed ID: 9752414
[No Abstract] [Full Text] [Related]
12. [An unusual complication of hepatocellular carcinoma: the pleuro-biliary fistula].
Tirotta D; Durante V
Recenti Prog Med; 2009 Feb; 100(2):84-6. PubMed ID: 19350800
[TBL] [Abstract][Full Text] [Related]
13. Transcatheter arterial chemoembolization in hepatocellular carcinoma: technique, effects and present status.
Paul SB; Guglani B; Gulati MS; Batra Y; Mukhopadhyay S
Trop Gastroenterol; 2003; 24(4):176-84. PubMed ID: 15164527
[No Abstract] [Full Text] [Related]
14. Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation.
Chapman WC; Majella Doyle MB; Stuart JE; Vachharajani N; Crippin JS; Anderson CD; Lowell JA; Shenoy S; Darcy MD; Brown DB
Ann Surg; 2008 Oct; 248(4):617-25. PubMed ID: 18936575
[TBL] [Abstract][Full Text] [Related]
15. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients.
Takayasu K; Arii S; Ikai I; Omata M; Okita K; Ichida T; Matsuyama Y; Nakanuma Y; Kojiro M; Makuuchi M; Yamaoka Y;
Gastroenterology; 2006 Aug; 131(2):461-9. PubMed ID: 16890600
[TBL] [Abstract][Full Text] [Related]
16. Intraarterial therapies for primary liver cancer: state of the art.
Chapiro J; Tacher V; Geschwind JF
Expert Rev Anticancer Ther; 2013 Oct; 13(10):1157-67. PubMed ID: 24099626
[TBL] [Abstract][Full Text] [Related]
17. Society of Interventional Radiology position statement on chemoembolization of hepatic malignancies.
Brown DB; Geschwind JF; Soulen MC; Millward SF; Sacks D
J Vasc Interv Radiol; 2006 Feb; 17(2 Pt 1):217-23. PubMed ID: 16517767
[No Abstract] [Full Text] [Related]
18. Closing remarks.
Kudo M
Clin Drug Investig; 2012 Aug; 32 Suppl 2():52. PubMed ID: 22873627
[No Abstract] [Full Text] [Related]
19. Prospective analysis of German patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization with or without prophylactic antibiotic therapy.
Plentz RR; Lankisch TO; Bastürk M; Müller CC; Kirchhoff T; Gebel M; Bleck JS; Kubicka S; Manns MP; Meier PN; Rudolph KL
J Gastroenterol Hepatol; 2005 Jul; 20(7):1134-6. PubMed ID: 15955232
[No Abstract] [Full Text] [Related]
20. Re: Society of Interventional Radiology position statement on chemoembolization of hepatic malignancies.
Covey AM; Maluccio MA; Brody LA; Sofocleous CT; Getrajdman GI; Brown KT
J Vasc Interv Radiol; 2006 Jul; 17(7):1209; author reply 1209-10. PubMed ID: 16868176
[No Abstract] [Full Text] [Related]
[Next] [New Search]
